Market Insights
Sinusitis is one of the most common upper respiratory tract infections with huge awareness in patents and medical professionals. Based on severity and nature, rhinosinusitis is classified into acute and chronic. It has been observed that most of the acute sinusitis cases are caused due to viral infection allied with a common cold. Most of the sinusitis cases are treated with decongestants, analgesics, and saline irrigation, particularly in patients to provide symptomatic relief. In addition, narrow-spectrum antibiotics are also prescribed in cases of acute sinusitis where disease conditions do not improve after 7 days.
According to Sinuwave Technologies Corporation, sinusitis affects around 40% of the population in the United States and results in around US$ 8.6 Bn in annual treatment expenditure every year. According to medical experts, acute sinusitis is usually of viral etiology and patients are treated with supportive therapies such as nasal irrigation. In the case of chronic sinusitis, patients are on multiple regimes of antibiotics, local & systemic corticosteroid therapy, and other drugs.
In the year 2017, decongestant & mucolytic agents dominated the market and expected to maintain its dominance throughout the forecast period. The key factors responsible for market growth are the first line of action for non-infectious sinusitis, upcoming novel technologies of drug delivery, and increasing patient-awareness has assisted the growth in disease diagnosis rate. During the forecast period from 2018 to 2016, antibiotics were observed as the fastest-growing segment due to key market drivers such as developing diagnostics technologies post introduction of rapid microbiology testing, its rampant use in infection treatment, and rising prevalence of bacterial infections.
North America dominated the sinusitis treatment drugs market due to key factors such as the rising prevalence of sinusitis coupled with developed diagnostic technologies, and high disease awareness in patients & medical practitioners. In addition, upcoming novel drug delivery technologies are expected to assist the market growth in the near future. During the forecast period from 2018 to 2026, Asia Pacific was observed as the fastest-growing region due to factors such as the rising prevalence of sinusitis along with increasing awareness about the nasal & sinus disorders in patients and developing healthcare infrastructure with skilled healthcare professionals. Swift urbanization and industrialization in key countries such as China, India, and Indonesia, leading to air pollution in urban areas and increasing the risk of sinusitis.
Market Competition Assessment:
The sinusitis treatment drugs market is matured and there are several companies operating in this market, comprises an ideal blend of domestic and global players.
Key Market Movements:
List of Companies Covered:
Market Segmentation:
By Treatment Type Segment
• Antibiotics
o Cephalosporin Antibiotics
o Penicillin Antibiotic / Β-lactamase Inhibitor Combinations
o Macrolide Antibiotics
o Quinolone Antibiotics
• NSAIDS
• Decongestant & Mucolytic
o Imidazoline Derivatives
o Antihistamines
o Corticosteroids
o α₁-adrenergic receptor agonist
• Nasal Irrigation Kits
By Geography Segment Type
Key questions answered in this report
The semiconductor industry is on the brink of a transformative era with the rapid adoption…
Overview Insurance fraud is a major challenge for the industry, leading to financial losses and…
Engineering plastics are rapidly gaining traction across multiple industries due to their superior mechanical properties,…
Micro-Electro-Mechanical Systems (MEMS) sensors are revolutionizing the automotive industry by enhancing vehicle safety, efficiency, and…
Forecasted for extraordinary growth, the global micro data centers market is set to expand from…
Dashcams, once considered a luxury gadget for car enthusiasts, have now become an essential tool…